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Abstract
Attention deficits and inappropriate regulation of sensory signal processing are hallmarks of many 
neuropsychiatric conditions, including attention deficit hyperactivity disorder (ADHD), for which 
methylphenidate (MPH) and atomoxetine (ATX) are commonly prescribed therapeutic treatments. 
Despite their widespread use and known mechanism of blocking reuptake of catecholamine 
transmitters in the brain, the resultant actions on individual neuron and neural circuit function that 
lead to therapeutic efficacy are poorly understood. Given the ability of MPH and ATX to improve 
cognitive performance in humans and rodent assays of attention, we were interested in their 
influence on early sensory processing in the dorsal lateral geniculate nucleus (dLGN), the primary 
thalamic relay for visual information from the retina to the visual cortex. In male rats, dLGN 
neuronal responses to light stimuli were altered in multiple ways following doses of MPH or ATX 
observed to enhance performance in visually-guided assays of attention in rats (MPH, 2 mg/kg; 
ATX, 0.5 mg/kg). Latencies to response onset and to the peak of the primary response were 
decreased, while the peak intensity and area of the primary response were increased. In addition, 
some cells that were unresponsive to light stimuli prior to drug treatment displayed a ‘gating 
effect,’ wherein prominent responses to light stimuli were evident following drug administration. 
Our results begin to reveal unique effects of MPH and ATX in enhancing sensory signal 
transmission through visual circuitry, and may yield new insights for understanding the 
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pathophysiology of certain cognitive disorders and inform development of improved therapeutic 
treatments for these conditions.
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Atomoxetine; Methylphenidate; Dorsal lateral geniculate nucleus; Norepinephrine; Sensory 
processing
Introduction
Efficient processing of sensory information is crucial for navigating our surroundings and 
facilitating adaptive behavioral responses to incoming stimuli within complex and dynamic 
environments. An essential element in this process is the ability to filter relevant information 
from an abundance of continuously streaming sensory input. Inappropriate regulation of 
sensory processing is associated with cognitive deficits common to many neuropsychiatric 
disorders, including schizophrenia, autism spectrum disorders, and attention deficit 
hyperactivity disorder (ADHD) (Javitt, 2009; Mangeot et al., 2001; Marco, Hinkley, Hill, & 
Nagarajan, 2011). ADHD is characterized by inattentiveness and/or hyperactivity and 
impulsiveness. ADHD patients are easily distracted by environmental stimuli that would 
otherwise be ignored. Thus, inappropriate sensory signal processing is a core deficit in these 
individuals. The psychostimulant drug, methylphenidate (MPH; Ritalin ®), and the non-
stimulant medication, atomoxetine (ATX; Strattera ®), are commonly prescribed treatments 
for patients with ADHD and have been reported to enhance attention in otherwise healthy 
individuals (Bidwell, McClernon, & Kollins, 2011; Greely et al., 2008; Swadlow & Gusev, 
2001; Swanson & Volkow, 2002). In addition, both MPH and ATX have been reported to 
improve elements of cognitive performance in a range of rodent assays that require attention 
and sensory-guided responses (Berridge et al., 2012; Cain, Wasserman, Waterhouse, & 
McGaughy, 2011; Jentsch, Aarde, & Seu, 2009; Navarra et al., 2008; Paterson, Ricciardi, 
Wetzler, & Hanania, 2011; Robinson, 2012). Despite the widespread clinical use and 
extensive pre-clinical investigation of cognitive function in animal models, the extent to 
which MPH and ATX alter the physiology of sensory circuits within the central nervous 
system to contribute to their attention-enhancing effects remain poorly understood.
MPH inhibits reuptake transporters of the catecholamine neurotransmitters, dopamine (DA) 
and norepinephrine (NE), while ATX is a selective NE transport inhibitor (Berridge et al., 
2006; Bymaster et al., 2002). Hence, MPH and ATX share a common mechanism of action 
by increasing extracellular levels of NE throughout the brain. The ascending locus coeruleus 
(LC)-NE pathway has been implicated in regulating behavioral states of arousal and 
modulating state dependent sensory processing (Berridge & Waterhouse, 2003). For 
example, Aston-Jones and colleagues (1997; 1994) demonstrated that LC neurons respond 
selectively to target visual stimuli according to the behavioral relevance of such signals, 
rather than to stimulus attributes. In addition, in this task of sustained attention, enhanced 
LC responsiveness was positively correlated with improved behavioral performance. At the 
cellular and circuit level, NE has been shown to potentiate stimulus-evoked discharge and 
enhance ‘signal to noise’ ratios of responses of sensory processing neurons and networks to 
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afferent stimuli throughout the brain (Berridge & Waterhouse, 2003). MPH was shown to 
facilitate the processing of incoming stimuli within the sensory cortex, consistent with 
increased NE in LC terminal fields (Drouin, Page, & Waterhouse, 2006; Drouin, Wang, & 
Waterhouse, 2007). This result indicates that MPH produces effects characteristic of NE-
induced modulation of sensory processing. As such, it is reasonable to predict that blockade 
of NE reuptake and subsequent elevation of NE concentrations in the LC terminal fields can 
facilitate processing of behaviorally relevant sensory information, and thereby improve 
performance in sensory-guided assays of attention.
The rat dorsal lateral geniculate nucleus (dLGN) of the thalamus is the primary sensory 
relay for visual information from the retina to the cortex and is of interest because it receives 
substantial input from the LC-NE system (Kromer & Moore, 1980; Latsari, Antonopoulos, 
Dori, Chiotelli, & Dinopoulos, 2004; Papadopoulos & Parnavelas, 1990). By contrast, DA 
innervation of the dLGN is minimal (García-Cabezas, Martínez-Sánchez, Sánchez-
González, Garzón, & Cavada, 2009). Electrical stimulation of the LC or direct application of 
NE within the dLGN increases spontaneous discharge of dLGN neurons and facilitates their 
response to afferent excitatory stimuli (Kayama, 1985; Kromer & Moore, 1980; Rogawski & 
Aghajanian, 1980a, 1980b) via alpha-1 (α1) post-synaptic adrenoreceptors (Kayama, 1985; 
Rogawski & Aghajanian, 1982). Given these effects and the mechanisms of action for MPH 
and ATX, we postulated facilitating effects of these agents on responses of dLGN neurons to 
visual stimuli. To this end, we investigated the effects of systemic administration of MPH 
and ATX on response properties of individual dLGN neurons in anesthetized rats.
Methods
Subjects
Nine male Sprague-Dawley rats (250 – 500 g) (Taconic; Germantown, NY) were housed in 
pairs prior to surgery and individually post-surgery. Rats were allowed to acclimate to the 
facility, which was temperature and humidity controlled, for at least one week following 
arrival and maintained under a 12/12 h light/dark cycle (lights on at 7:00 AM) with ad 
libitum access to food and water. All experimental procedures were conducted in accordance 
with the guidelines of the National Institutes of Health Guide for the Care and Use of 
Laboratory Animals, and protocols were approved by the Drexel University Institutional 
Animal Care and Use Committee.
Drugs
MPH and ATX were purchased from Sigma-Aldrich (St. Louis, MO). Drugs were dissolved 
in sterile saline and administered via intraperitoneal (i.p.) injection in a dosing volume of 1 
mg/ml. Doses of MPH (2 mg/kg, i.p.) and ATX (0.5 mg/kg, i.p.) were chosen in accordance 
with multiple reports of these drugs enhancing measures of cognitive function in normal 
adult rats (Navarra, Graf et al. 2008; Jentsch, Aarde et al. 2009; Cain, Wasserman et al. 
2011; Paterson, Ricciardi et al. 2011; Berridge, Shumsky et al. 2012; Robinson 2012). These 
doses are also within the range that produce plasma concentrations for exerting therapeutic 
effects in patients with ADHD and for improving cognitive function in healthy adult humans 
(Sauer, Ring, & Witcher, 2005; Swanson & Volkow, 2002). Specifically, plasma 
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concentrations following administration of clinically efficacious doses of MPH are within 
the range of 8 – 40 ng/ml (Swanson & Volkow, 2002) and similar plasma levels are obtained 
after administration of cognitive-enhancing doses in rats (Berridge et al., 2006).
Surgery
Animals were anesthetized with isoflourane (4% induction, maintained at 1 – 2% in 95% O2 
5% CO2) and positioned in flat skull orientation in a stereotaxic frame with atraumatic ear 
bars. Body temperature was monitored and maintained at 37°C using a rectal probe 
thermometer and a heating pad. The skull surface was exposed and 4 – 6 jeweler’s screws 
were fixed to the skull to secure electrode implants. Eight-bundle microelectrodes of 
formvar-insulated nichrome wires (25μm; A-M Systems, Sequim, WA) were fitted into 
electrically grounded 26G guide cannulae and implanted bilaterally in the dLGNs of the 
thalamus (AP –4.8, ML ±3.8, DV –4.0) using stereotaxic coordinates (Paxinos & Watson, 
2007). Electrode placement was verified using previously established anatomical and 
neurophysiological criteria for dLGN thalamic neurons, including activity evoked by light 
stimulation presented to the contralateral eye with a primary response peak latency prior to 
65 msec (Marks, Speciale, & Roffwarg, 1988). Electrode implants were then secured using a 
connector and dental cement and subjects were allowed to recover for at least one week prior 
to recording experiments or underwent experimental recording procedures during a terminal 
surgical session on the same day.
Single-unit recording
For all experimental procedures, the animal was placed in a stereotaxic apparatus with 
atraumatic ear bars under light isoflourane anesthesia (~2% in 95% O2 5% CO2). A light 
emitting diode (LED; RadioShack© white, clear lens LED light with luminous intensity: 
1100 mcd, chromaticity coordinates: 660, viewing angle: 100 deg) was positioned centrally 
1 cm in front of and above the head along the midline, and the room was darkened. Stimuli 
of three different intensities (5 msec duration) were delivered in pseudorandom order at a 
rate of 2 stimuli/sec (Hz) using a CED 1401 and a script written using Spike2 software 
(CED, Cambridge, England). Electrical activity was amplified and discriminated in real time 
using a combination of acquisition, spike discrimination, and analysis software (Sort Client 
and NeuroExplorer; Plexon Inc., Dallas, TX) to isolate single-unit waveforms and create 
cumulative raster plots and peri-stimulus time histograms (PSTHs) of the activity of light-
responsive single-units within the dLGN. All recorded activity was stored for off-line 
analysis. Single-unit activity was re-sorted off-line, according to waveform characteristics 
and inter-spike interval distribution patterns including peak voltage of the waveform, 
waveform slopes, scattergram of the waveform’s first two principal components, spike train 
auto-correlogram, and inter-spike interval histogram (Offline Sorter; Plexon). Following 
sorting, PSTHs representing single-unit responses were constructed for each stimulus 
intensity and drug condition, then plotted using bin widths of 1 msec with boxcar smoothing 
across 3 adjacent bins. Unit responses were examined during vehicle pre-treatment and drug 
post-treatment conditions.
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Analysis of electrophysiological data
Data were analyzed using custom routines written in MATLAB (MathWorks, Inc., Natick, 
MA). The parameters of neuronal function that were assessed included baseline firing rates 
and primary light-evoked response properties, including latency to response onset, latency to 
maximum response, maximum response amplitude, and response area as depicted in Figure 
1a. Mean baseline firing rates represented as frequency in impulses/sec were calculated over 
100 msec prior to stimulus presentation. Onset and offset of primary response peaks in the 
PSTHs were determined as the time where two or more consecutive bins crossing a 
threshold of 3 standard deviations above the average baseline discharge. Onset latencies less 
than 65 msec were considered to represent primary responses to stimuli, and peaks with 
longer latencies were excluded from further analysis. Maximum peak amplitude and peak 
response area (the sum of all bin values from peak onset to peak offset) were corrected for 
background firing rate by subtracting the mean baseline firing rate from each post-stimulus 
bin. ‘Gating’ was declared for cells that were initially unresponsive to light stimuli of a 
given intensity but demonstrated prominent responses to the same intensity stimulus 
following drug administration. For each cell PSTHs from unit activity were constructed of 
15 min intervals under vehicle pre-drug conditions, then again beginning at 15 min 
following MPH administration (n = 63 units) or 30 min following ATX administration (n = 
47 units). Additional control studies included analysis of PSTHs constructed from unit 
activity collected during a 15 min saline condition time-matched to the vehicle pre-drug 
condition examined in MPH and ATX studies, then again following a second saline 
administration, beginning at 15 min to match the MPH administration, and again at 30 min 
to match ATX administration (n = 26 units). Post-treatment evaluation times were chosen in 
accordance with time scales reported to demonstrate significant increase of extracellular 
catecholamine concentrations in the brain (Bymaster et al., 2002) and correspond to 
clinically relevant plasma levels following administration of MPH in rats (Berridge et al., 
2006).
Light-responsive units were classified according to their pre-drug control responses to the 
three different light stimulus intensities; type I cells responded to high intensity stimuli only, 
type II responded to both high and intermediate intensity stimuli, and type III cells 
responded to all three stimulus intensities – high, intermediate, and low (see Figure 1b). 
Because distributions of most PSTH parameters were substantially non-normal, and 
transformations that normalized some group data simultaneously de-normalized others, 
Kruskal-Wallis tests with post-hoc Dunn’s multiple comparison tests were used to compare 
responses among stimulus intensities. Single-units that responded to a given stimulus in both 
pre- and post-treatment epochs were further analyzed with Wilcoxon matched-pairs signed 
rank tests, comparing pre-treatment to post-treatment PSTHs, both for MPH and ATX. 
Drug-induced changes in light-evoked discharge were expressed as percentages [(post-
treatment – pre-treatment/pre-treatment) x 100]. Mann Whitney tests were used to compare 
these values to those observed for neurons recorded from rats that received consecutive 
saline (SAL-SAL) injections. Fisher’s exact tests were used to test whether drug 
administration exerted differential ‘gating’ effects on neurons that exhibited responses to low 
versus intermediate intensity stimuli. Statistical analyses and preparation of figures were 
performed using Prism (GraphPad Software, Inc.) and NeuroExplorer (Plexon) software.
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Upon completion of experiments, animals were deeply anesthetized and perfused with 4% 
paraformaldehyde. Brains were extracted, frozen, sectioned and mounted in 30 μm slices 
through the dLGN, and counterstained with neutral red for verification of electrode tracks 
terminating in the dLGN (Figure 1c).
Results
Prior to drug treatment and time-matched vehicle post-treatment, one hundred and thirty two 
light-responsive cells were recorded from the dLGN of nine animals. The distribution of 
cells responding to light stimuli of different intensities was as follows: type I (high only) = 
47/132 cells; type II (high and intermediate) = 67/132 cells; type III (high, intermediate, and 
low) = 18/132 cells (Figure 1b). The effect of decreasing stimulus intensity on the properties 
of light sensitive neurons was evaluated. There was an overall effect of stimulus intensity on 
the latency to onset of response (p < 0.0001) with post-hoc analysis revealing that latencies 
increased in response to low intensity stimuli as compared to intermediate and high 
intensities (p < 0.05; Figure 2a). Latency to the maximum response was also affected by 
stimulus intensity (p < 0.0001) with post-hoc tests revealing that latency increased in 
response to the low intensity stimulus compared to intermediate and high intensities (p < 
0.05; Figure 2b). The maximum peak amplitude and the response peak area were 
significantly decreased as stimulus intensity decreased (p < 0.05 and p = 0.005, respectively) 
with post-hoc tests revealing significantly smaller magnitudes of response to the low 
stimulus compared to the high in both conditions (p < 0.05; Figure 2c and d, respectively). 
Overall, these data indicate that response latencies increase and response magnitudes 
decrease as stimulus intensity decreases.
Both MPH and ATX facilitated responses of dLGN neurons to light stimuli. Figure 3 (MPH; 
3a, and ATX; 3b) illustrates typical cases where drugs decreased the latency and increased 
the magnitude of a single-unit response to high and intermediate intensity stimuli. Note also 
that a response to the intermediate or low intensity stimulus was not evident under control 
(pre-treatment) conditions but became prominent following drug administration with either 
MPH or ATX, i.e. ‘gating.’
Effects of MPH on dLGN neuronal responses to visual stimulation
The effects of MPH on responses to high and intermediate intensity stimuli were tested in n 
= 60 cells recorded from six animals. The bivariate scatter plots in Figures 4 and 5 show the 
values for latency and magnitude measures for each cell in vehicle pre-treatment condition 
on the x-axis versus drug post-treatment condition on the y-axis for large and intermediate 
intensity stimuli (there were only four cells that responded to low intensity stimuli, and they 
are not represented in Figure 4). Points clustering below the line of identity for latency 
measures indicate cells whose latencies were greater in vehicle compared to drug condition, 
signifying a decrease in response latencies or faster responses following drug administration. 
Additionally, points clustering above the line of identity for measures of magnitude indicate 
cases where cell responses to light stimuli increased in magnitude following drug treatment. 
MPH administration significantly decreased the latencies of response to high intensity 
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stimuli (median difference in onset latency = −3 msec, p < 0.0001; Figure 4a, median 
difference in peak latency = −1 msec, p < 0.001). Following MPH treatment, the maximum 
amplitude of the response was increased (median difference = 6.9 impulses/sec, p < 0.0001) 
as was the area of the response peak (median difference = 40.9 impulses/sec, p < 0.001; 
Figure 4b).
MPH also reduced the latencies to response onset (median difference = −1.5 msec, p < 
0.005; Figure 4c) and to the maximum response (median difference = −2 msec, p < 0.005) 
for intermediate intensity stimuli. Correspondingly, the maximum response amplitude 
(median difference = 5.6 impulses/sec, p < 0.005) and the area of the response peak (median 
difference = 22.8 impulses/sec, p < 0.01; Figure 4d) were significantly increased for medium 
intensity stimuli following MPH treatment. These results indicate that dLGN neurons 
respond more quickly and more robustly to both high and intermediate intensity light stimuli 
after systemic administration of MPH.
Visual inspection of Figure 4 suggests that the MPH-induced changes in PSTH peaks are not 
uniformly distributed across the ranges of response properties in the sample. Latencies to 
response onset (Figure 4a and c) or to peak response exhibit an overall pattern where the 
shortest latencies are more or less evenly distributed about the line of identity, while the 
points with the longest vehicle pre-treatment latencies fall predominantly below the line, 
indicating that the latencies of the slowest-responding cells are most likely to be impacted by 
MPH administration. In contrast, the peak magnitude measures (Figure 4b and d) suggest 
that whereas responses to intermediate intensity stimuli were almost all increased by MPH, 
irrespective of initial peak size, the responses to high intensity stimuli increased 
proportionately more if they were relatively small under vehicle treatment conditions. 
Together these observations suggest a ceiling effect: peaks that are small and/or slow 
initially are enhanced by MPH, whereas peaks that are initially large and/or fast are less 
affected.
Effects of ATX on dLGN neuronal responses to visual stimulation
The effects of ATX on responses to high and intermediate intensity stimuli were tested in n 
= 46 cells recorded from five animals. Results were broadly comparable to those seen with 
MPH treatment. For high intensity stimuli, the latencies to response onset and to peak 
response were significantly decreased with ATX treatment (median difference = −1 msec, p 
< 0.05 (Figure 5a) and p < 0.05, respectively), and the magnitude measures were 
significantly increased (amplitude; median difference = 7.3 impulses/sec, p < 0.0001; area, 
median difference = 60.8 impulses/sec, p < 0.001; Figure 5b).
In response to the medium intensity stimulus, there was a significant decrease in latency to 
the response onset (median difference = −3.5 msec, p < 0.0001; Figure 5c) and a trend 
toward decreased latency to the maximum response (median difference = −0.5 msec, p = 
0.09). Both measures of peak magnitude in response to the intermediate stimulus were 
significantly increased following ATX (amplitude median difference = 6.3 impulses/sec, p < 
0.0001; area median difference = 69.9 impulses/sec, p < 0.0001, Figure 5d). These results 
indicate that as with MPH, the responses of dLGN neurons to light stimuli occur more 
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quickly and more robustly following ATX treatment. With one exception, ATX facilitated 
neural responses following the same pattern of enhancing modulatory effects.
The scatterplot patterns in Figure 5 for ATX are not as clear as those of Figure 4 for MPH. 
Nevertheless, the trends are similar; latency shifts tend to be greater for slower responding 
cells (Figure 5a and c) and cells with initially smaller response amplitudes are increased to a 
greater extent than those with initially larger magnitude responses (Figure 5b and d). The net 
effect of these changes brought about by MPH and ATX is a stronger and faster response of 
the dLGN visual relay circuit to light stimuli.
Percent change in visually-evoked neuronal activity following post-treatment conditions
An additional three animals (n = 26 cells) received a second administration of saline to 
construct PSTHs corresponding with MPH and ATX post-treatment time point analyses and 
serve as further control conditions. For the high intensity stimulus, the percent change in the 
latency to response onset (p < 0.0005; Figure 6a) and the latency to the maximum response 
(p < 0.005) following MPH significantly differed from the saline time-matched control, with 
MPH decreasing the latencies to a greater degree than its time-matched saline control. 
Percent changes in response magnitudes to the high intensity stimulus (amplitude; p < 
0.0001, and area; p < 0.0005; Figure 6b) were also significantly increased to a greater extent. 
For the intermediate intensity stimulus, MPH did not significantly alter onset latency 
compared to time-matched saline (p > 0.05; Figure 6c), but it did reduce peak latency (p < 
0.0005). Both measures of magnitude had significantly greater percent changes following 
MPH in response to the intermediate intensity stimulus (amplitude; p < 0.0001, and area; p < 
0.0001; Figure 6d).
Compared to time-matched controls, ATX also significantly shortened latencies (p < 0.01 – 
p < 0.0005), except for the onset latency of the response to the high intensity stimulus (p > 
0.05; Figure 7). As observed with MPH, both measures of magnitude (peak amplitude and 
area) exhibited significantly greater percent changes following ATX in response to both high 
and intermediate intensity stimuli (p < 0.0001 for each comparison; Figure 7).
Gating effects of MPH and ATX across stimulus intensities
Neurons were also examined for gating effects following MPH and ATX administration. 
Gating of sensory-evoked discharges in noradrenergic terminal fields has been observed 
previously following LC stimulation or local application of NE in both cortical and thalamic 
sensory circuits (Devilbiss & Waterhouse, 2011; Waterhouse et al., 1988). In these previous 
experiments, neurons initially unresponsive to afferent sensory inputs become responsive 
during periods of elevated noradrenergic neurotransmission. In the current study, this 
analysis was limited to cells that were initially light-responsive to at least the high intensity 
stimuli. As a result, the available pool of cells in which gating could be observed was 
limited; n = 60 cells following MPH administration and n = 46 cells following ATX 
administration. After MPH, 15 of 28 neurons previously unresponsive to the intermediate 
intensity stimuli exhibited a response and 3/57 became responsive to low intensity stimuli. 
Similarly, after ATX, 12 of 19 previously unresponsive neurons exhibited a response to 
intermediate intensity stimuli and 2/45 responded to low intensity stimuli. Thus, this analysis 
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showed that following treatment with either MPH or ATX, gating effects were greater in 
response to the intermediate intensity stimulus as compared to the low intensity stimulus (p 
< 0.0001 against the null hypothesis of equal proportions of neurons gated from the available 
pool of neurons for each intensity tested; Figure 6a and b), indicating that pharmacological 
manipulation is more likely to induce responsiveness to an intermediate intensity stimulus 
than to a small intensity stimulus. In addition to the above sample, cells with no prior 
response to light stimuli at any intensity exhibited responses to high intensity stimuli for 
three neurons following MPH administration and one neuron following ATX administration. 
Overall, the results indicate that MPH and ATX can recruit neurons into the sensory 
response pool.
Discussion
The results of the current study show that MPH and ATX, two agents used in the treatment 
of ADHD, popular for enhancing cognitive function in otherwise healthy people, and 
effective in enhancing rodent performance in sensory-guided attention tasks, exert prominent 
facilitating effects on early sensory signal processing in the rat visual thalamus. Both MPH 
and ATX enhanced the responses of dLGN neurons, reducing the latency and increasing the 
magnitude of responses to light stimuli, resembling the changes associated with increasing 
stimulus intensity. Neurons with weaker and/or longer latency responses realized the greatest 
gains following drug administration as observed by Drouin et al. (2007) in the sensory 
cortex following systemic MPH treatment. In addition, many cells that were previously 
unresponsive to light stimuli exhibited well defined responses to visual inputs following 
MPH or ATX treatment, indicating that both agents were capable of gating responses of 
dLGN neurons to otherwise sub-threshold stimuli and recruiting these cells into the sensory 
response pool. As a result of these actions, light-evoked responses in the dLGN circuitry had 
shorter latencies and were more robust following drug administration, indicating that 
attention-enhancing drugs can affect early sensory processing. Previous studies have 
provided evidence that more efficient processing of visual information in the dLGN 
strengthens the dynamics of synaptic transmission to the visual cortex, thus increasing 
information transfer to cortical targets and facilitating higher order processing of visual 
signals (Alonso, Usrey, & Reid, 1996; Saalmann & Kastner, 2009; Swadlow & Gusev, 
2001). This early facilitation of visual processing may lead to improvements in cognitive 
performance under conditions where attention to visual cues is necessary for favorable 
behavioral outcomes.
The local mechanisms underlying drug-induced modulation of light-evoked dLGN responses 
require further investigation. The dLGN receives direct input from the retina, but retino-
geniculate projections account for less than 10% of the input to this nucleus (Van Horn, 
Erişir, & Sherman, 2000). Ninety percent of the afferents to the dLGN are derived from 
areas other than the retina and thus could serve as sources of modulatory influences to this 
thalamic relay nucleus (Kayama, 1985; Kromer & Moore, 1980; Papadopoulos & 
Parnavelas, 1990; Van Horn et al., 2000). MPH blocks reuptake of both NE and DA, thereby 
increasing the extracellular concentrations of these transmitters in catecholamine terminal 
fields (Bymaster et al., 2002). However, the high selectivity of ATX for blocking NE, but not 
DA, transporters suggests that modulation of sensory-evoked responses as observed here is 
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dependent upon increased noradrenergic transmission. This interpretation is further 
supported by reports that DA innervation of the dLGN is sparse if not non-existent (García-
Cabezas et al., 2009).
Facilitation of signal processing in sensory circuits by the LC-NE system is well 
documented, as reviewed by Berridge and Waterhouse (2003). Likewise, noradrenergic 
‘gating’ actions have also been demonstrated in both thalamic and cortical regions of the 
brain (Devilbiss & Waterhouse, 2011; Waterhouse et al., 1988). More specifically, 
enhancement of dLGN neuronal responses to excitatory synaptic inputs by LC stimulation 
or local iontophoretic application of NE has been linked to activation of α1 receptors 
(Kayama, 1985; Kromer & Moore, 1980; Rogawski & Aghajanian, 1980a, 1980b, 1982). 
Together with these previous results, the present findings suggest that the facilitating effects 
of MPH and ATX on dLGN signal processing are the result of blockade of NE transporter 
function leading to elevated extracellular levels of NE within the dLGN and local α1 
mediated modulatory influences on stimulus-driven excitation.
In addition to local modulation within the dLGN, the remote actions of MPH and ATX on 
neural circuitry afferent to the dLGN could be responsible for alterations in responses to 
light stimuli. A likely target in such a scenario would be the visual cortex, which sends 
feedback to dLGN, directly and indirectly via the thalamic reticular nucleus, and is a 
prominent recipient of noradrenergic projections from the LC. Considering possibilities 
relevant to the relationship between attention and sensory processing, MPH and ATX are 
both capable of increasing both NE and DA in the prefrontal cortex (PFC). The PFC is a 
cortical region associated with abnormal catecholaminergic neurotransmission in ADHD 
(Arnsten & Pliszka, 2011) and may influence the dLGN via projections to the LC (Jodo, 
Chiang, & Aston-Jones, 1998). DA elevation in the PFC depends on the NE reuptake 
transporter (NET), given the relative abundance of NET over dopamine transporters (DAT) 
within the PFC (Carboni, Tanda, Frau, & Chiara, 1990; Sesack, Hawrylak, Matus, Guido, & 
Levey, 1998). Thus, both drugs could be impacting dLGN function via NE and DA 
mechanisms in the PFC. Local drug infusion studies are currently underway to address the 
consequences of remote effects as well as the contribution of additional neuromodulatory 
systems, such as DA, that may influence dLGN neuronal responses.
It is important to acknowledge seemingly paradoxical reports that both MPH and ATX dose-
dependently decrease, not increase, tonic output from the LC (Bari & Aston-Jones, 2013; 
Devilbiss & Berridge, 2006). However, the results of microdialysis studies (Berridge et al., 
2006; Bymaster et al., 2002; Drouin et al., 2006) indicate that the net impact of blocking NE 
transporter uptake following systemic drug administration is increased extracellular levels of 
NE in noradrenergic terminal fields, resulting in the facilitation of stimulus-driven responses 
(Devilbiss & Berridge, 2008; Drouin et al., 2007).
Our results demonstrate the potential for cognitive-enhancing agents to facilitate early 
sensory processing within the dLGN by increasing the speed of transmission and magnitude 
of response to visual stimuli. As modulation of sensory processing is deficient in disorders 
of cognitive function, these findings suggest that improvement of sensory signal processing 
may be a prominent dimension of the therapeutic action of MPH and ATX in attention 
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disorders. Likewise, the effects demonstrated here could translate to improved sensory 
function in normal individuals, thus providing at least one physiological explanation for off-
label use of these agents as cognitive enhancers (Greely et al., 2008). In addition, our 
findings provide insight regarding interpretation of the results of recent reports that 
demonstrated facilitating effects of attention on early visual signal processing in the LGN of 
both monkeys (McAlonan, Cavanaugh, & Wurtz, 2008) and humans (O'Connor, Fukui, 
Pinsk, & Kastner, 2002; Schneider & Kastner, 2009). For example, McAlonan et al. (2008) 
showed that LGN activity was greater in response to a peripheral stimulus when monkeys 
covertly directed attention to that stimulus during a fixation task of selective attention. Taken 
together, the ability of MPH and ATX to enhance performance in tasks of attention, the 
impact of these agents on early sensory signal processing as shown here, and the evidence 
that states of attention modulate LGN circuit function collectively point to early sensory 
signal processing as a prominent site of action for cognitive enhancing drugs. Overall, the 
results of the current work indicate that further efforts to elucidate the mechanisms by which 
attention-enhancing medications influence early sensory processing may yield new insights 
regarding the pathophysiology of attention disorders and lead to development of improved 
therapeutic treatments.
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Representative response properties of visually-sensitive cells and histological verification of 
electrode placement within the rat dLGN. a) Raster plot of single-unit activity and 
corresponding PSTH of visually-evoked discharge with respect to light stimuli (arrow at 
time = 0 msec) recorded from a single-unit in the rat dLGN. Properties of primary light-
evoked responses are shown, including latency to response onset, latency to maximum peak 
response, maximum peak amplitude, and peak response area. b) Three representative types 
of single-units recorded from the dLGN with different thresholds for stimulus intensity. Top: 
type I, n = 47/132 cells that responded to high stimuli only, middle: type II, n = 67/106 cells 
that responded to high and intermediate stimuli, and bottom: type III, n = 18 cells that 
responded to all three stimuli. Spike rate intensities represented as frequency in impulses/
second (imp/sec) in b) and c) are plotted in bin widths of 1msec with boxcar smoothing 
across 3 adjacent bins. c) Representative coronal section through the dLGN of the rat 
thalamus collected from one of the subjects upon completion of experimental procedures. 
Left: corresponding location as depicted in the stereotaxic atlas of the rat brain (Paxinos & 
Watson, 2007). Right: magnification (top = 1.6x, bottom = 5x) of the electrode guide 
cannula and electrode tracts terminating in the dLGN.
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Effects of stimulus intensity on properties of light-evoked responses in the dLGN. Mean and 
SEM of response properties across decreasing stimulus intensities. N = 132 cells responded 
to the high intensity stimulus, a subset of these (n = 85/132 cells) responded to the 
intermediate intensity stimulus, and four cells (n = 18/106) responded to all three stimuli. * 
denotes p < 0.05 between pairs of stimulus intensity.
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Representative PSTHs illustrate the effects of drug treatment (a; methylphenidate; MPH, and 
b; atomoxetine; ATX) on responses of a single dLGN neuron to high, intermediate, and low 
intensity visual stimuli. Histograms are aligned to stimulus onset (time = 0) for each 
stimulus intensity. Stimuli of three intensities were presented in pseudorandom order at 2 Hz 
across pre-treatment control (top) and drug post-treatment (bottom) conditions. Spike rate 
intensities represented as frequency in impulses/second (imp/sec) are plotted using bin 
widths of 1 msec with boxcar smoothing across 3 adjacent bins. Dashed lines: an example of 
decreased latency to response onset following drug post-treatment. Dotted lines: an example 
of decreased latency to peak response following drug post-treatment. Numeric values offset 
from histogram peaks represent maximum peak amplitude (top) and response peak area 
(bottom), respectively in impulses/second (imp/sec). Arrow denotes an example of a gated 
response, i.e. one that is not evident under control conditions but becomes apparent 
following ATX administration.
Navarra et al. Page 16














Effects of methylphenidate (MPH) on properties of visually-evoked responses in the dLGN. 
Bivariate scatter plots represent vehicle on the x-axis by MPH on the y-axis values for 
properties of neuronal activity in response to both high (a, b) and intermediate (c, d) 
stimulus intensities. Points clustering above the 45 degree equivalence line indicate that 
there was increase in the response measure following MPH treatment whereas those below 
the line indicate that there was a decrease in the response measure following MPH 
treatment. * below the line of identity denotes a significant decrease (p < 0.05) in measures 
post-MPH treatment and above the line of identity denotes a significant increase (p < 0.05) 
in measures post-MPH treatment.
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Effects of atomoxetine (ATX) on properties of visually-evoked responses in the dLGN. 
Bivariate scatter plots represent vehicle on the x-axis by ATX on the y-axis values for 
properties of neuronal activity in response to both high and intermediate stimulus intensities. 
Points clustering above the 45 degree equivalence line indicate that there was increase in the 
response measure following ATX treatment and below indicate that there was a decrease in 
the response measure following ATX treatment. * below the line of identity denotes a 
significant decrease (p < 0.05) in measures post-ATX treatment and above the line of 
identity denotes a significant increase (p < 0.05) in measures post-ATX treatment.
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Percent change in latency and magnitude of visually-evoked responses following 
methylphenidate (MPH) as compared to saline (SAL) time-matched control. Percent 
changes following MPH (n = 60 cells) or SAL (n = 26) were calculated as [(post-treatment – 
pre-treatment/pre-treatment) x 100]. * denotes significance (p < 0.05) of post-treatment 
effect between groups.
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Percent change in latency and magnitude of visually-evoked responses following 
atomoxetine (ATX) as compared to saline (SAL) time-matched control. Percent changes 
following ATX (n = 46 cells) or SAL (n = 26) were calculated as [(post-treatment – pre-
treatment/pre-treatment) x 100]. * denotes significance (p < 0.05) of post-treatment effect 
between groups.
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Treatment-induced responsiveness of visually-sensitive dLGN neurons. Illustrated by the bar 
graphs are the number of cells that discharged in response to light stimuli under pre-
treatment control conditions (light gray) and the number of additional cells where stimulus-
evoked discharge became evident following drug treatment; i.e. “gated” responses (dark 
gray) for each stimulus intensity; high, intermediate (Int), and low. * denotes p < 0.0001 
against the null hypothesis of equal proportions of neurons recruited from available pools of 
neurons between stimulus intensities.
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